The vector of anti-GD2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human GD2. The T cells are genetically modified through transduction with a retroviral vector expressing scFv of anti-GD2 antibody linked to DAP10 signaling domains. And the vector product was designed for the treatment of GD2 positive cancers.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-CAR-LC765||Lenti-GD2 CAR (scFv-TCR ζ chain, 14g2a) Viral Particle|
|CAR-MZ021||Anti-GD2 scFv h(CD28-OX40-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC767||Lenti-GD2 CAR (scFv-CD28-41BB-TCR ζ chain, 14g2a) Viral Particle|
|VP-CAR-LC867||Lenti-GD2 CAR (scFv-CD3ζ, Clone 126) Viral Particle|
|CAR-MZ175||Anti-GD2 (Clone 126) h(41BB-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC768||Lenti-GD2 CAR (scFv-41BB-CD3ζ) Viral Particle|
|CAR-MZ054||Anti-GD2 (Dinutuximab) scFv h(41BB-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC766||Lenti-GD2 CAR (scFv-41BB-TCR ζ chain, 14g2a) Viral Particle|
|CAR-MZ174||Anti-GD2 (Clone 126) h(CD28-CD3ζ) CAR, Pcdcar1|
|CAR-MZ047||Anti-GD2 (14g2a) h(CD28-41BB-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved